Determinants of left ventricular mass in children with autosomal recessive polycystic kidney disease

Mathew Lin1, Jeremy Rubin2, Robert A Palermo3,4

  • 1Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Journal of Nephrology
|October 6, 2025
PubMed

Insights

In children with autosomal recessive polycystic kidney disease (ARPKD), left ventricular (LV) mass was not linked to blood pressure but showed a negative association with kidney function (eGFR). Young patients often have hypertension.

Area of Science:

  • Pediatric Nephrology
  • Cardiology
  • Genetics

Background:

  • Hypertension and left ventricular hypertrophy (LVH) are prevalent in children with autosomal recessive polycystic kidney disease (ARPKD).
  • Understanding the determinants of left ventricular (LV) mass is crucial for managing cardiovascular risk in this population.

Purpose of the Study:

  • To investigate the clinical factors associated with LV mass in pediatric patients diagnosed with ARPKD.
  • To explore the relationship between blood pressure parameters, renal function, and LV mass in children with ARPKD.

Main Methods:

  • Retrospective analysis of echocardiogram data from 30 children with ARPKD.
  • Collected data included casual blood pressure (BP) percentiles, 24-h ambulatory BP monitoring (ABPM) parameters, antihypertensive medication use, and estimated glomerular filtration rate (eGFR).
  • Outcomes assessed were LV mass Z-score, LV mass index (LVMI), and the presence of LVH.

Main Results:

  • LVH was observed in 23% to 50% of patients based on different LVMI criteria.
  • Younger age correlated with increased antihypertensive use and higher BP percentiles.
  • LV mass was not significantly associated with casual BP or ABPM after adjusting for covariates, but showed a negative association with eGFR.

Conclusions:

  • Young children with ARPKD exhibit a significant burden of hypertension.
  • Left ventricular mass in pediatric ARPKD is unexpectedly not associated with blood pressure but is negatively correlated with estimated glomerular filtration rate (eGFR).
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
189
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
215
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
460